Description
CV70 is a 1,8-Diaza-anthracene-tetrone compound that exhibits anticancer activity in vitro, inhibiting the activation of JNK and ERK5.
CV70 is a 1,8-Diaza-anthracene-tetrone compound that exhibits anticancer activity in vitro, inhibiting the activation of JNK and ERK5.
Purity | ≥70% |
---|---|
Formula | C16H14N2O4 |
Formula Wt. | 298.29 |
Appearance | Red Powder |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet | |
Brochures |
Pipaón C, Gutierrez P, Montero JC, et al. Mitogen-activated protein kinase routes as targets in the action of diaza-anthracene compounds with a potent growth-inhibitory effect on cancer cells. Mol Cancer Ther. 2002 Aug;1(10):811-9. PMID: 12492114.
Phenylamino pyridine; Abl, c-Kit, PDGFR, PP2A i...
Carnitine derivative, involved in energy homeos...
Xanthine derivative; PDE inhibitor.
PI3K and mTOR inhibitor.
FIASMA, 5-HT1/2, M1-5 mAChR, α1-adrenergic, hi...
Mycotoxin produced by various fungi including t...
Cathelicidin derivative, antimicrobial peptide,...
Fluoroquinolone, S-(-) isomer of ofloxacin; top...
Estradiol metabolite; microtubule depolymerizat...
Antihistamine with potential neuroprotective ac...
FLT3, PDGFR, c-Kit inhibitor.
Endogenous peptide hormone, counteracts insulin...
FIASMA, μOR agonist, potential HCN channel blo...
Glucosinolate found in cruciferous vegetables.<...
Amino amide; voltage-gated Na+, BK/SK, Kv1, Kv3...
Fluoroquinolone; bacterial DNA gyrase inhibitor...
NSAID; COX-1/2 and PDE inhibitor.
Binds to neurotoxin receptor site 2 on voltage-...
5-HT3 antagonist.
HSP90 inhibitor.